WHO ICTRP trial
Assessment of the effects of telmisalthan and olmethaltan on blood pressure…
JPRN-UMIN000002422 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000002422 |
|---|---|
| Public title | Assessment of the effects of telmisalthan and olmethaltan on blood pressure, proteinuria, inflammation and oxidative stress in chronic kidney disease patients |
| Scientific title | Assessment of the effects of telmisalthan and olmethaltan on blood pressure, proteinuria, inflammation and oxidative stress in chronic kidney disease patients - Pleiotropic effect of telmisalthan and olmethaltan |
| Primary sponsor | Division of Nephrology Department of Medicine, Showa University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Chronic kidney disease stage 3-5 |
| Interventions | olmesartan |
| Registration date | Jul 9, 2009 |
| Target size | 30 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: